At-home STI self-swab testing offered with telemedicine medication abortion
Official title: STI Self-swab Testing At the Time of Telemed Medication Abortion Provision
Run by Queen's Medical Center · NCT06951438 · Data updated 2026-11-12
This project will try offering at-home self-collected vaginal swab tests for chlamydia, gonorrhea, and trichomonas to people getting medication abortion by telemedicine in Hawai'i to see if patients use and accept it.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years and up |
| Sex | Women only |
| Enrollment | 75 (estimated) |
| Sponsor | Queen's Medical Center Academic / other |
| Locations | 1 site (Honolulu, Hawaii) |
| Status | Recruiting |
| Started | May 22, 2025 |
| Main results expected | April 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | June 26, 2025 |
| Trial ID | NCT06951438 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People aged 14 and older seeking medication abortion by telemedicine through Queen's Medical Center Options Center in Hawai'i who can read English and either meet CDC indications for STI testing or desire screening are eligible.
✕Probably not a fit
Individuals living outside the state of Hawai'i, those who are incarcerated, or those unwilling or unable to perform a vaginal self-swab (or who cannot access telehealth) may not receive benefit from this service.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This exploratory interventional cohort compares telemedicine medication abortion patients who are offered an at-home self-collected vaginal swab for PCR testing of chlamydia, gonorrhea, and trichomonas to a contemporaneous in-clinic cohort via chart review. Telemedicine participants across the Hawaiian Islands who are eligible for STI testing or request screening are recruited at the time of their abortion televisit and receive instructions and a kit for self-collection. Primary outcomes include acceptability, feasibility, uptake, STI positivity rates, and average time from testing to treatment for positives. The study is conducted through the Queen's Medical Center Options Center in Honolulu, Hawai'i.
Why it matters
Potential benefit: If successful, this approach could increase access to timely STI screening and faster treatment for people obtaining medication abortion by telemedicine in Hawai'i.
How similar studies have gone: Prior research shows self-collected vaginal swabs with PCR are accurate and acceptable for chlamydia, gonorrhea, and trichomonas, though packaging this service specifically at the time of telemedicine medication abortion is a newer application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients of the Queen Medical Center Options Center clinic seeking telemedicine medication abortion. 2. Patients for whom, according to the CDC guidelines for STI Testing11, STI testing is indicated, or patients who desire STI screening 3. Age 14 and over 4. Can speak and read English 5. Displays capacity for informed consent Exclusion Criteria: 1. Home address that is not located in the state of Hawai'i 2. Incarcerated 3. Unwilling to perform vaginal swab collection
Where it's running
-
Queens Medical Center, 1004 Clinic POB1
Honolulu, Hawaii, United States Recruiting
Study contacts
- Study coordinator: Olivia H Manayan, MD, MPH
- Email: omanayan@hawaii.edu
- Phone: 808-348-7859
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Doxycycline after sex to prevent gonorrhea, chlamydia, and syphilis in MSM in Bangkok
This research tests whether taking doxycycline after sex can prevent gonorrhea, chlamydia, and syphilis in men who have sex with men in Bangkok.
-
Doxycycline Prophylaxis to Prevent STIs in Adolescent and Young Women
This trial tests whether taking doxycycline after sex or every week can reduce gonorrhea, chlamydia, and early syphilis in girls and young women, compared with usual care.
-
Free testing and treatment program for chlamydia, gonorrhea, syphilis, and HIV
This program offers free testing for four STIs and provides counseling and no-cost expedited treatment options for Black people aged 15–26 who live or spend most of their time in Orleans Parish.
-
Improving relationship education to reduce HIV rates among sexual and gender minorities
This study is testing a new relationship education program to see if it can help reduce HIV rates among gay, bisexual, queer, and transgender individuals who are in relationships with cisgender men.
-
Observing HIV infection risks among high-risk individuals in Vienna
This study looks at the risk factors for new HIV infections among HIV-negative men who have sex with men and transgender individuals in Vienna to better understand how the virus spreads in these groups.
-
Doxycycline to prevent bacterial STIs in sexual and gender minorities in Rio de Janeiro.
This research will try taking doxycycline after sex to see if it lowers the chance of syphilis, gonorrhea, and chlamydia for men who have sex with men, transgender women, and travestis in Rio de Janeiro who are living with HIV or using PrEP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.